Search

Your search keyword '"Eurosida Study Group"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Eurosida Study Group" Remove constraint Author: "Eurosida Study Group" Language english Remove constraint Language: english
38 results on '"Eurosida Study Group"'

Search Results

1. Observational cohort study of rilpivirine (RPV) utilization in Europe

2. Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

Catalog

Books, media, physical & digital resources

3. A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy

4. Impact of HIV-1 Reverse Transcriptase Polymorphism F214L on Virological Response to Thymidine Analogue-Based Regimens in Antiretroviral Therapy (ART)-Naive and ART-Experienced Patients

11. Regional and temporal changes in AIDS in Europe before HAART

12. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

13. Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings

14. Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination Antiretroviral therapy in the EuroSIDA study

15. Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART

16. Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study

17. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

18. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens.

21. A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA Study.

22. Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/µl in the era of cART.

23. Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients.

24. Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C.

25. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: A EuroSIDA Study.

27. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

29. Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study.

32. The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.

34. Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

35. AIDS across Europe, 1994-98: the EuroSIDA study.

36. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study

37. Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study